Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa-Reference-Cited by-同舟云学术

Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa

Published:2020-08-31 Issue:11 Volume:40 Page:2643-2654
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Baudoin Mael¹,Woode Maame E.²^ORCID,Nishimwe Marie Libérée¹^ORCID,Lemoine Maud³^ORCID,Sylla Babacar⁴,Kouanfack Charles⁵⁶,Moh Raoul⁷⁸^ORCID,Seydi Moussa⁹,Rouveau Nicolas¹⁰,Attia Alain¹¹,Lacombe Karine¹²¹³^ORCID,Boyer Sylvie¹^ORCID

Affiliation:

1. Aix Marseille Univ, INSERM, IRD SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale Marseille France

2. Centre for Health Economics Monash University Melbourne Vic. Australia

3. Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology and Gastroenterology St Mary's Hospital, Imperial College London UK

4. IMEA Paris France

5. Faculté de Médecine et des Sciences Pharmaceutiques Université de Dschang Dschang Cameroun

6. Hôpital de Jour Hôpital Central de Yaoundé Yaounde Cameroun

7. MEREVA PACCI Abidjan Abidjan Côte d'Ivoire

8. Unité Pédagogique de Dermatologie et Infectiologie, UFR des sciences médicales Abidjan Côte d'Ivoire

9. Service des Maladies infectieuses et Tropicales CHU Fann Dakar Sénégal

10. ANRS Paris France

11. Service d'hépatologie CHU Yopougon Abidjan Côte d'Ivoire

12. Sorbonne Université INSERM Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP Paris France

13. APHP Hôpital Saint‐Antoine Service de Maladies Infectieuses et Tropicales Paris France

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14613

Reference47 articles.

1. WHO.WHO. Global hepatitis report 2017. WHO.http://www.who.int/hepatitis/publications/global‐hepatitis‐report2017/en/. Accessed February 19 2020

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Natural history of hepatitis C

4. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

5. Battlefield against hepatitis B infection and HCC in Africa

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial);Scientific Reports;2024-05-03

2. Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial;2023-11-28